194 related articles for article (PubMed ID: 37244938)
21. Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice.
Oliveira AC; de Alencar BC; Tzelepis F; Klezewsky W; da Silva RN; Neves FS; Cavalcanti GS; Boscardin S; Nunes MP; Santiago MF; Nóbrega A; Rodrigues MM; Bellio M
PLoS Pathog; 2010 Apr; 6(4):e1000870. PubMed ID: 20442858
[TBL] [Abstract][Full Text] [Related]
22. Myd88 is required for an antibody response to retroviral infection.
Browne EP; Littman DR
PLoS Pathog; 2009 Feb; 5(2):e1000298. PubMed ID: 19214214
[TBL] [Abstract][Full Text] [Related]
23. NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses.
Krebs P; Barnes MJ; Lampe K; Whitley K; Bahjat KS; Beutler B; Janssen E; Hoebe K
Blood; 2009 Jun; 113(26):6593-602. PubMed ID: 19406986
[TBL] [Abstract][Full Text] [Related]
24. MyD88-dependent signaling drives host survival and early cytokine production during Histoplasma capsulatum infection.
Coady A; Sil A
Infect Immun; 2015 Apr; 83(4):1265-75. PubMed ID: 25583527
[TBL] [Abstract][Full Text] [Related]
25. The lipopolysaccharide adjuvant effect on T cells relies on nonoverlapping contributions from the MyD88 pathway and CD11c+ cells.
McAleer JP; Zammit DJ; Lefrançois L; Rossi RJ; Vella AT
J Immunol; 2007 Nov; 179(10):6524-35. PubMed ID: 17982041
[TBL] [Abstract][Full Text] [Related]
26. Attenuated Toxoplasma gondii Stimulates Immunity to Pancreatic Cancer by Manipulation of Myeloid Cell Populations.
Sanders KL; Fox BA; Bzik DJ
Cancer Immunol Res; 2015 Aug; 3(8):891-901. PubMed ID: 25804437
[TBL] [Abstract][Full Text] [Related]
27. Surface immunogenic protein from Streptococcus agalactiae and
Díaz-Dinamarca DA; Salazar ML; Escobar DF; Castillo BN; Valdebenito B; Díaz P; Manubens A; Salazar F; Troncoso MF; Lavandero S; Díaz J; Becker MI; Vásquez AE
Front Immunol; 2023; 14():1186188. PubMed ID: 37790926
[TBL] [Abstract][Full Text] [Related]
28. Unique Roles of TLR9- and MyD88-Dependent and -Independent Pathways in Adaptive Immune Responses to AAV-Mediated Gene Transfer.
Rogers GL; Suzuki M; Zolotukhin I; Markusic DM; Morel LM; Lee B; Ertl HC; Herzog RW
J Innate Immun; 2015; 7(3):302-14. PubMed ID: 25612611
[TBL] [Abstract][Full Text] [Related]
29. Evaluating vaccinia virus cytokine co-expression in TLR GKO mice.
Sutherland DB; Ranasinghe C; Regner M; Phipps S; Matthaei KI; Day SL; Ramshaw IA
Immunol Cell Biol; 2011 Aug; 89(6):706-15. PubMed ID: 21173782
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant activity of naturally occurring monophosphoryl lipopolysaccharide preparations from mucosa-associated bacteria.
Chilton PM; Hadel DM; To TT; Mitchell TC; Darveau RP
Infect Immun; 2013 Sep; 81(9):3317-25. PubMed ID: 23798540
[TBL] [Abstract][Full Text] [Related]
31. Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner.
Werthmöller N; Frey B; Wunderlich R; Fietkau R; Gaipl US
Cell Death Dis; 2015 May; 6(5):e1761. PubMed ID: 25973681
[TBL] [Abstract][Full Text] [Related]
32. MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection.
Zhou S; Kurt-Jones EA; Mandell L; Cerny A; Chan M; Golenbock DT; Finberg RW
Eur J Immunol; 2005 Mar; 35(3):822-30. PubMed ID: 15724245
[TBL] [Abstract][Full Text] [Related]
33. MyD88 plays a critical T cell-intrinsic role in supporting CD8 T cell expansion during acute lymphocytic choriomeningitis virus infection.
Rahman AH; Cui W; Larosa DF; Taylor DK; Zhang J; Goldstein DR; Wherry EJ; Kaech SM; Turka LA
J Immunol; 2008 Sep; 181(6):3804-10. PubMed ID: 18768833
[TBL] [Abstract][Full Text] [Related]
34. Priming of CD8+ T-cell responses after DNA immunization is impaired in TLR9- and MyD88-deficient mice.
Pavlenko M; Leder C; Moreno S; Levitsky V; Pisa P
Vaccine; 2007 Aug; 25(34):6341-7. PubMed ID: 17628235
[TBL] [Abstract][Full Text] [Related]
35. Blockade of Myd88 signaling induces antitumor effects by skewing the immunosuppressive function of myeloid-derived suppressor cells.
Hong EH; Chang SY; Lee BR; Kim YS; Lee JM; Kang CY; Kweon MN; Ko HJ
Int J Cancer; 2013 Jun; 132(12):2839-48. PubMed ID: 23184679
[TBL] [Abstract][Full Text] [Related]
36. Differential role of MyD88 and TRIF signaling in myeloid cells in the pathogenesis of autoimmune diabetes.
Androulidaki A; Wachsmuth L; Polykratis A; Pasparakis M
PLoS One; 2018; 13(3):e0194048. PubMed ID: 29522531
[TBL] [Abstract][Full Text] [Related]
37. Targeting the genital tract mucosa with a lipopeptide/recombinant adenovirus prime/boost vaccine induces potent and long-lasting CD8+ T cell immunity against herpes: importance of MyD88.
Zhang X; Dervillez X; Chentoufi AA; Badakhshan T; Bettahi I; Benmohamed L
J Immunol; 2012 Nov; 189(9):4496-509. PubMed ID: 23018456
[TBL] [Abstract][Full Text] [Related]
38. Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation.
Kaisho T; Hoshino K; Iwabe T; Takeuchi O; Yasui T; Akira S
Int Immunol; 2002 Jul; 14(7):695-700. PubMed ID: 12096028
[TBL] [Abstract][Full Text] [Related]
39. A West Nile virus NS4B-P38G mutant strain induces adaptive immunity via TLR7-MyD88-dependent and independent signaling pathways.
Xie G; Welte T; Wang J; Whiteman MC; Wicker JA; Saxena V; Cong Y; Barrett AD; Wang T
Vaccine; 2013 Aug; 31(38):4143-51. PubMed ID: 23845800
[TBL] [Abstract][Full Text] [Related]
40. B cell-intrinsic MyD88 signaling controls IFN-γ-mediated early IgG2c class switching in mice in response to a particulate adjuvant.
Lee MSJ; Natsume-Kitatani Y; Temizoz B; Fujita Y; Konishi A; Matsuda K; Igari Y; Tsukui T; Kobiyama K; Kuroda E; Onishi M; Marichal T; Ise W; Inoue T; Kurosaki T; Mizuguchi K; Akira S; Ishii KJ; Coban C
Eur J Immunol; 2019 Sep; 49(9):1433-1440. PubMed ID: 31087643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
